{
  "company": {
    "name": "Mestag Therapeutics",
    "website": "https://mestagtherapeutics.com/",
    "record": "https://startuphistory.org/c/mestagtherapeutics.com"
  },
  "status": null,
  "history_since": "2021-08-02T05:50:52.000Z",
  "baseline": {
    "snapshot_id": "007b6bab78f6f9455288891e04bd906409c0fb2d5728d67fb52fa3124cf82e83",
    "observed_at": "2021-08-02T05:50:52.000Z",
    "headline": null,
    "description": "Mestag Therapeutics was established in 2020 to develop impactful new medicines for people affected by inflammatory disease and cancer.",
    "evidence": "https://web.archive.org/web/20210802055052/https://mestagtherapeutics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:41:31.438Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:41:31.438Z",
      "variants": [
        {
          "headline": "Driving fibroblast-immune conversations in cancer and inflammatory diseases",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2023-01-06T20:36:24.000Z",
          "evidence": "https://web.archive.org/web/20230106203624/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Driving fibroblast-immune conversations in cancer and inflammatory diseases",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2023-10-01T05:47:25.000Z",
          "evidence": "https://web.archive.org/web/20231001054725/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Driving fibroblast-immune conversations in cancer and inflammatory diseases",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2024-07-23T20:04:02.000Z",
          "evidence": "https://web.archive.org/web/20240723200402/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "New therapeutics for cancer and inflammatory diseases targeting fibroblast immunology",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2025-01-13T20:31:11.000Z",
          "evidence": "https://web.archive.org/web/20250113203111/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "New therapeutics for cancer and inflammatory diseases targeting fibroblast immunology",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2025-08-05T08:26:06.000Z",
          "evidence": "https://web.archive.org/web/20250805082606/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "New therapeutics for cancer and inflammatory diseases targeting fibroblast immunology",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2026-01-04T03:53:13.000Z",
          "evidence": "https://web.archive.org/web/20260104035313/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "New therapeutics for cancer and inflammatory diseases targeting fibroblast immunology",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2026-10-21T04:37:16.000Z",
          "evidence": "https://web.archive.org/web/20261021043716/https://www.mestagtherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "New therapeutics for cancer and inflammatory diseases targeting fibroblast immunology",
          "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
          "observed_at": "2026-11-06T17:41:31.438Z",
          "evidence": "https://www.mestagtherapeutics.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "New therapeutics for cancer and inflammatory diseases targeting fibroblast immunology",
      "subhead": "Driving fibroblast-immune conversations in cancer and inflammatory diseases.",
      "from": "2023-01-06T20:36:24.000Z",
      "to": "2026-11-06T17:41:31.438Z",
      "captures": 8,
      "evidence": "https://www.mestagtherapeutics.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2023-01-06T20:36:24.000Z",
          "to": "2026-11-06T17:41:31.438Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Agomab Therapeutics",
      "record": "https://startuphistory.org/c/agomab.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both develop antibody therapies aimed at fibro-inflammatory or fibrotic biology in immune-related diseases."
    },
    {
      "name": "Uniquity Bio",
      "record": "https://startuphistory.org/c/uniquity.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both discover and advance antibody therapeutics for immune-mediated inflammatory diseases."
    },
    {
      "name": "Allakos",
      "record": "https://startuphistory.org/c/allakos.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both are developing antibody-based therapeutics for inflammatory and immune-mediated diseases."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Mestag Therapeutics” company record, https://startuphistory.org/c/mestagtherapeutics.com"
}